The Official Website of the Long-Term Investor
Results 1 - 10 of 10244 : 1 2 3 4 5 6 7 8 9 Next
Have J&J's Approval Hopes Vanished?
Johnson & Johnson might have trouble sidestepping the competition.
The Better Way to Play Berkshire
Buffett's talents as a stock picker may service investors better if they simply build a portfolio of his holdings rather than buy his company's stock.
5-Star Stocks Poised to Pop: UnitedHealth
Market-trouncing returns could be written in this five-star.
Drug Fails: At Least It's Approved Already
Pfizer's Torisel fails to best Nexavar in a head-to-head trial.
FDA advisory panel recommends approving rheumatoid arthritis drug tofacitinib.
Rheumatoid arthritis drug tofacitinib could be a blockbuster.
Where the best are finding value.
Are Falling Knives Worth Catching?
Big one-day drops make stocks look attractive, but they don't always make smart buying points.
Pfizer Looks Fine Post-Tornado
Earnings statement gets jumbled up post-Lipitor, breakup.
5-Star Stocks Poised to Pop: Becton Dickinson
Market-trouncing returns could be written in this 5-Star.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK